🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “pituitary-adenoma”

NARecruitingNCT04569591 ↗

DDAVP for Pituitary Adenoma

👨‍⚕️ Prashant Chittiboina, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT07456878 ↗

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

👨‍⚕️ Neetu Soni, MBBS, MD, Mayo Clinic📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07268183 ↗

How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors

🏥 Hospices Civils de Lyon📍 1 site📅 Started Jan 2026View details ↗
NAEnrolling by InvitationNCT07108244 ↗

Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

🏥 University Hospital, Basel, Switzerland📍 2 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07045935 ↗

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

👨‍⚕️ Cihan Atila, Dr., University Hospital Basel, Dept. of Endocrinology, Metabolism & Diabetes📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT05971758 ↗

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

🏥 University of California, Los Angeles📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06584123 ↗

Molecular Pituitary Imaging Using 18F-FET PET

👨‍⚕️ Mark Gurnell, MD, PhD, Cambridge University Hospitals NHS Foundation Trust📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT07335315 ↗

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

👨‍⚕️ Ian Mark, MD, Mayo Clinic📍 1 site📅 Started Jun 2024View details ↗
NAEnrolling by InvitationNCT06297473 ↗

Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.

👨‍⚕️ Jesper Krogh, DMSc, Zealand University Hospital📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06163261 ↗

Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma

🏥 Vastra Gotaland Region📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT07463625 ↗

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

🏥 Hospices Civils de Lyon📍 1 site📅 Started Nov 2023View details ↗
Phase 4RecruitingNCT06448195 ↗

Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

👨‍⚕️ Tao Xie, Fudan University📍 1 site📅 Started Jan 2023View details ↗
Phase 4RecruitingNCT04107480 ↗

PRolaCT - Three Prolactinoma RCTs

👨‍⚕️ Nienke R Biermasz, MD, prof., Endocrinologist LUMC📍 3 sites📅 Started Jun 2019View details ↗
RecruitingNCT03831958 ↗

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

👨‍⚕️ Deborah P Merke, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)📍 1 site📅 Started Mar 2019View details ↗
Phase 2RecruitingNCT03774446 ↗

Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

👨‍⚕️ Shlomo Melmed, MD, Cedars-Sinai Medical Center📍 1 site📅 Started Nov 2018View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →